News

New toxicological data demonstrates a carbon heated tobacco product presents less risk of harm to smokers in comparison to cigarettes.

Research reveals the immune system of farmed hens does not mature by the time they are culled for their meat, at six months of age.

Two immune system molecules may be key to the development of drug resistance in estrogen-driven breast cancers.

Study reveals possible drug targets for cancers with a faulty PTEN gene.

Funding from a National Science Foundation CAREER Award is being used to develop spinal tissue that can be easily grown in a laboratory.

Using a new tool for editing genomes, known as CRISPR, researchers have genetically engineered immune cells and improved the ability of these cells to kill cancer cells in mice.

After three patients were blinded following a treatment marketed as a stem cell clinical trial, Stanford ophthalmologist Jeffrey Goldberg calls for increased patient education and regulation.

The first in a new class of gene-silencing drugs, known as inclisiran, has halved cholesterol levels in patients at risk of cardiovascular disease.

MIT researchers have devised a way to make tumor cells more susceptible to certain types of cancer treatment by coating the cells with nanoparticles before delivering drugs.

The FDA approval is based on the superior efficacy and demonstrated safety of Kisqali plus letrozole versus letrozole alone in a pivotal clinical trial.